A single-dose viral vector-based rabies vaccine shows strong, sustained antibody responses in adults and children with a good safety profile at 1 year.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.